三星醫療(601567.SH):中標合計約6.39億元國家電網相關採購項目
格隆匯11月23日丨三星醫療(601567.SH)公佈,公司及全資子公司寧波三星智能電氣有限公司(簡稱“三星智能”或“子公司”)於近日收到國家電網有限公司及國網物資有限公司發給公司及子公司的中標通知書,在“國家電網有限公司2022年第六十一批採購(營銷項目第二次電能表(含用電信息採集)招標採購)”(招標編號:0711-22OTL14822019)及“國家電網有限公司2022年第六十二批採購(營銷項目第二次充換電設備協議庫存招標採購)”(招標編號:0711-22OTL15022020)的招標活動中,公司及子公司分別為兩個項目的中標人。
其中電能表類中標A級單相智能電能表、B級三相智能電能表、C級三相智能電能表、D級三相智能電能表、集中器及採集器、專變採集終端(含能源控制器專變),共中16個標包,中標金額約為6.24億元;充換電設備類中標金額約為1479.35萬元;合計中標金額約為6.39億元。
此次中標總金額約為6.39億元人民幣,佔公司2021年度經審計的營業總收入的9.10%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.